Tags

Type your tag names separated by a space and hit enter

Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.
Exp Neurol. 2002 Feb; 173(2):183-95.EN

Abstract

Doubly transgenic mice expressing both a mutated amyloid precursor protein and a mutated presenilin-1 protein accumulate A(beta) deposits as they age. The early A(beta) deposits were found to be primarily composed of fibrillar A(beta) and resembled compact amyloid plaques. As the mice aged, nonfibrillar A(beta) deposits increased in number and spread to regions not typically associated with amyloid plaques in Alzheimer's disease. The fibrillar, amyloid-containing deposits remained restricted to cortical and hippocampal structures and did not increase substantially beyond the 12-month time point. Even at early time points, the fibrillar deposits were associated with dystrophic neurites and activated astrocytes expressing elevated levels of glial fibrillary acidic protein. Microglia similarly demonstrated increased staining for complement receptor-3 in the vicinity of A(beta) deposits at early time points. However, when MHC-II staining was used to assess the degree of microglial activation, full activation was not detected until mice were 12 months or older. Overall, the regional pattern of A(beta) staining resembles that found in Alzheimer disease; however, a progression from diffuse A(beta) to more compact amyloid deposits is not observed in the mouse model. It is noted that the activation of microglia at 12 months is coincident with the apparent stabilization of fibrillar A(beta) deposits, raising the possibility that activated microglia might clear fibrillar A(beta) deposits at a rate similar to their rate of formation, thereby establishing a relatively steady-state level of amyloid-containing deposits.

Authors+Show Affiliations

Alzheimer Research Laboratory, Department of Pharmacology, University of South Florida, Tampa, Florida 33612-4799, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

11822882

Citation

Gordon, Marcia N., et al. "Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP Mouse." Experimental Neurology, vol. 173, no. 2, 2002, pp. 183-95.
Gordon MN, Holcomb LA, Jantzen PT, et al. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse. Exp Neurol. 2002;173(2):183-95.
Gordon, M. N., Holcomb, L. A., Jantzen, P. T., DiCarlo, G., Wilcock, D., Boyett, K. W., Connor, K., Melachrino, J., O'Callaghan, J. P., & Morgan, D. (2002). Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse. Experimental Neurology, 173(2), 183-95.
Gordon MN, et al. Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP Mouse. Exp Neurol. 2002;173(2):183-95. PubMed PMID: 11822882.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse. AU - Gordon,Marcia N, AU - Holcomb,Leigh A, AU - Jantzen,Paul T, AU - DiCarlo,Giovanni, AU - Wilcock,Donna, AU - Boyett,Kristal W, AU - Connor,Karen, AU - Melachrino,Jason, AU - O'Callaghan,James P, AU - Morgan,Dave, PY - 2002/2/2/pubmed PY - 2002/3/1/medline PY - 2002/2/2/entrez SP - 183 EP - 95 JF - Experimental neurology JO - Exp Neurol VL - 173 IS - 2 N2 - Doubly transgenic mice expressing both a mutated amyloid precursor protein and a mutated presenilin-1 protein accumulate A(beta) deposits as they age. The early A(beta) deposits were found to be primarily composed of fibrillar A(beta) and resembled compact amyloid plaques. As the mice aged, nonfibrillar A(beta) deposits increased in number and spread to regions not typically associated with amyloid plaques in Alzheimer's disease. The fibrillar, amyloid-containing deposits remained restricted to cortical and hippocampal structures and did not increase substantially beyond the 12-month time point. Even at early time points, the fibrillar deposits were associated with dystrophic neurites and activated astrocytes expressing elevated levels of glial fibrillary acidic protein. Microglia similarly demonstrated increased staining for complement receptor-3 in the vicinity of A(beta) deposits at early time points. However, when MHC-II staining was used to assess the degree of microglial activation, full activation was not detected until mice were 12 months or older. Overall, the regional pattern of A(beta) staining resembles that found in Alzheimer disease; however, a progression from diffuse A(beta) to more compact amyloid deposits is not observed in the mouse model. It is noted that the activation of microglia at 12 months is coincident with the apparent stabilization of fibrillar A(beta) deposits, raising the possibility that activated microglia might clear fibrillar A(beta) deposits at a rate similar to their rate of formation, thereby establishing a relatively steady-state level of amyloid-containing deposits. SN - 0014-4886 UR - https://www.unboundmedicine.com/medline/citation/11822882/Time_course_of_the_development_of_Alzheimer_like_pathology_in_the_doubly_transgenic_PS1+APP_mouse_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0014488601977544 DB - PRIME DP - Unbound Medicine ER -